CYLTEZO (ADALIMUMAB-ADBM) — FDA Approval BLA761058 (BOEHRINGER INGELHEIM)
CYLTEZO (ADALIMUMAB-ADBM) — FDA Approval BLA761058 (BOEHRINGER INGELHEIM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CYLTEZO; Active ingredients: ADALIMUMAB-ADBM; Application number: BLA761058.
| Brand name | CYLTEZO |
|---|---|
| Active ingredients | ADALIMUMAB-ADBM |
| Application number | BLA761058 |
| Sponsor | BOEHRINGER INGELHEIM |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20170825 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →